908 Devices (MASS) Cash from Financing Activities (2020 - 2026)

908 Devices' (MASS) quarterly Cash from Financing Activities came in at -$2.2 million in Q1 2026, down 1047.09% year-on-year from $228911.7 in Q1 2025, and down 423.67% on a QoQ basis from -$414000.0 in Q4 2025.

908 Devices (MASS) Cash from Financing Activities (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Cash from Financing Activities data on file, last reported at -$2.2 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 1047.09% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$2.7 million, a 466.58% decrease from a year earlier, with the FY2025 full-year figure at -$697000.0, down 85.37% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$2.2 million, down from -$414000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MASS reached as high as $529000.0 in Q4 2024 and fell as low as -$15.4 million in Q1 2023.
  • Historically, Cash from Financing Activities has averaged -$1.1 million across 5 years, with a median of -$16000.0 in 2025.
  • Across the five-year window, Cash from Financing Activities plunged 11931.54% in 2023 and jumped 456.84% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $411000.0 in 2022, then tumbled by 76.89% to $95000.0 in 2023, then soared by 456.84% to $529000.0 in 2024, then tumbled by 178.26% to -$414000.0 in 2025, then tumbled by 423.67% to -$2.2 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$2.2 million in Q1 2026, -$414000.0 in Q4 2025, and -$16000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn 17.31 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn -451.20 Mn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 21.00 Mn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn -25.00 Mn
8 Smith & Nephew 26.77 Bn 26.20 Bn - -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn -26.93 Mn
10 908 Devices 269.51 Mn 157.77 Mn 6.88 Mn -2.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.17 Mn
Mar 31, 2026 -2.17 Mn
Dec 31, 2025 -414,000.00
Dec 31, 2025 -414,000.00
Sep 30, 2025 -16,000.00
Sep 30, 2025 -16,000.00
Jun 30, 2025 -78,000.00
Jun 30, 2025 -78,000.00
Mar 31, 2025 -189,000.00
Mar 31, 2025 -189,000.00
Dec 31, 2024 529,000.00
Dec 31, 2024 529,000.00
Sep 30, 2024 23,000.00
Sep 30, 2024 23,000.00
Jun 30, 2024 367,000.00
Jun 30, 2024 367,000.00
Mar 31, 2024 -1.30 Mn
Mar 31, 2024 -1.30 Mn
Dec 31, 2023 95,000.00
Dec 31, 2023 95,000.00